Three stocks that can be pillars for your portfolio -- likely to rise in value over time while also paying a dividend -- are Eli Lilly (NYSE: LLY), Starbucks (NASDAQ: SBUX), and Visa (NYSE: V). Drugmaker Eli Lilly has a solid business that has generated an annual operating profit of at least 25% in each of the past three years. A number of Eli Lilly's drugs have experienced year-to-date growth of more than 20%, including its top-selling diabetes drug, Trulicity.
Each company benefits as consumers return to restaurants, but one fell farther and one has more upside going forward.
Like much of the restaurant industry, Starbucks (NASDAQ: SBUX) ran into some headwinds early in the pandemic, but the company has bounced back vigorously thanks to a strong digital channel, contribution from drive-thru stores, and the ability to adapt its stores to changing needs, including social distancing. In this segment from The Five, recorded on Sept. 1, Fool.com contributors Jeremy Bowman and Jason Hall discuss why Starbucks looks like a great choice for a recovery stock. Jason Hall: Today, we got ADP's payroll report.